Garrison Bradford & Associates’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-6,468
| Closed | -$2.39M | – | 61 |
|
|
2024
Q4 | $2.39M | Sell |
6,468
-799
| -11% | -$295K | 2.5% | 13 |
|
|
2024
Q3 | $3.78M | Buy |
7,267
+135
| +2% | +$70.2K | 3.75% | 8 |
|
|
2024
Q2 | $3.87M | Hold |
7,132
| – | – | 3.97% | 8 |
|
|
2024
Q1 | $3.7M | Sell |
7,132
-3
| -0% | -$1.56K | 3.81% | 8 |
|
|
2023
Q4 | $3.37M | Sell |
7,135
-586
| -8% | -$276K | 3.71% | 8 |
|
|
2023
Q3 | $3.36M | Buy |
7,721
+463
| +6% | +$202K | 3.97% | 7 |
|
|
2023
Q2 | $3.23M | Buy |
7,258
+1
| +0% | +$444 | 3.9% | 7 |
|
|
2023
Q1 | $3.34M | Sell |
7,257
-399
| -5% | -$183K | 4.13% | 7 |
|
|
2022
Q4 | $3.93M | Sell |
7,656
-149
| -2% | -$76.4K | 4.76% | 6 |
|
|
2022
Q3 | $3.55M | Buy |
7,805
+92
| +1% | +$41.8K | 4.31% | 6 |
|
|
2022
Q2 | $3.72M | Buy |
7,713
+3
| +0% | +$1.45K | 4.23% | 6 |
|
|
2022
Q1 | $3.79M | Sell |
7,710
-59
| -0.8% | -$29K | 3.68% | 8 |
|
|
2021
Q4 | $3.6M | Sell |
7,769
-150
| -2% | -$69.5K | 3.23% | 8 |
|
|
2021
Q3 | $2.95M | Buy |
7,919
+1
| +0% | +$373 | 3% | 10 |
|
|
2021
Q2 | $3.02M | Sell |
7,918
-199
| -2% | -$76K | 3.14% | 10 |
|
|
2021
Q1 | $2.91M | Buy |
8,117
+961
| +13% | +$345K | 3.25% | 10 |
|
|
2020
Q4 | $2.3M | Buy |
7,156
+3,421
| +92% | +$1.1M | 2.8% | 10 |
|
|
2020
Q3 | $1M | Buy |
+3,735
| New | +$1M | 1.41% | 18 |
|